Back
EyePoint Pharmaceuticals Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
64
EYPT
EyePoint Pharmaceuticals
Last Price:
8.92
Seasonality Move:
-14.68%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- The current trend is relatively stagnant and EYPT is experiencing slight buying pressure.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.85 | Buy |
| 20-day SMA: | 8.69 | Buy |
| 50-day SMA: | 8.88 | Buy |
| 200-day SMA: | 16.38 | Sell |
| 8-day EMA: | 8.84 | Buy |
| 20-day EMA: | 8.71 | Buy |
| 50-day EMA: | 9.07 | Sell |
| 200-day EMA: | 12.31 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 52.77 | Buy |
| Chaikin Money Flow: | 19446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.13 - 9.09) | Buy |
| Bollinger Bands (100): | (7.58 - 12.06) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.92 while EYPT 8-day simple moving average is 8.85, which is a Buy signal.
- The stock price of EYPT is 8.92 while EyePoint Pharmaceuticals 20-day SMA is 8.69, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day simple moving average is 8.88 while EYPT share price is 8.92, making it a Buy technically.
- EYPT stock price is 8.92 and EyePoint Pharmaceuticals 200-day simple moving average is 16.38, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Buy
64
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Buy
The current EyePoint Pharmaceuticals [EYPT] share price is $8.92. The Score for EYPT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
477.38M
Price in USD:
8.92
Share Volume:
816.71K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.67
Buy
64
EyePoint Pharmaceuticals (EYPT)
is a Buy
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 8.92 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is not overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.92 while EYPT 8-day exponential moving average is 8.84, which is a Buy signal.
- The stock price of EYPT is 8.92 while EyePoint Pharmaceuticals 20-day EMA is 8.71, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day exponential moving average is 9.07 while EYPT share price is 8.92, making it a Sell technically.
- EYPT stock price is 8.92 and EyePoint Pharmaceuticals 200-day simple moving average is 12.31, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting EyePoint Pharmaceuticals is a Buy
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 52.77, which suggest EyePoint Pharmaceuticals is overbought
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (8.13 - 9.09), which suggest EyePoint Pharmaceuticals is a Sell
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (7.58 - 12.06), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.